Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
作者信息
Di Iorio Biagio R, Bellasi Antonio, Raphael Kalani L, Santoro Domenico, Aucella Filippo, Garofano Luciano, Ceccarelli Michele, Di Lullo Luca, Capolongo Giovanna, Di Iorio Mattia, Guastaferro Pasquale, Capasso Giovambattista
机构信息
Nephrology and Dialysis Unit, PO "A. Landolfi", Solofra, Avellino, Italy.
Nephrology and Dialysis, "Antonio Cardarelli" hospital, Naples, Italia.
出版信息
J Nephrol. 2020 Jun;33(3):619-620. doi: 10.1007/s40620-020-00742-z.
Abstract
It occurred to us that a simple but significant calculation error was made in Table 2 in the dose of bicarbonate administered. Indeed, contrary to what reported in Table 2, the dose of sodium bicarbonate administered during study was.
摘要
相似文献
1
Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
J Nephrol. 2020 Jun;33(3):619-620. doi: 10.1007/s40620-020-00742-z.
2
A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.一项前瞻性、多中心、随机、对照研究：慢性肾功能不全患者（UBI 研究）使用碳酸氢盐纠正代谢性酸中毒。
J Nephrol. 2012 May-Jun;25(3):437-40. doi: 10.5301/jn.5000014.
3
Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.纠正代谢性酸中毒可改善慢性肾脏病患者的胰岛素抵抗。
BMC Nephrol. 2016 Oct 22;17(1):158. doi: 10.1186/s12882-016-0372-x.
4
Correction of chronic metabolic acidosis for chronic kidney disease patients.慢性肾脏病患者慢性代谢性酸中毒的纠正。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001890. doi: 10.1002/14651858.CD001890.pub3.
5
6
Adaptation of HCO-3 and NH+4 transport in rat MTAL: effects of chronic metabolic acidosis and Na+ intake.大鼠髓袢升支粗段中HCO-3和NH+4转运的适应性：慢性代谢性酸中毒和钠摄入的影响
Am J Physiol. 1990 May;258(5 Pt 2):F1345-53. doi: 10.1152/ajprenal.1990.258.5.F1345.
7
[Sodium bicarbonate to slow the progression of chronic kidney disease].[碳酸氢钠延缓慢性肾脏病进展]
Rev Med Suisse. 2011 Mar 2;7(284):478-82.
8
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.维维美尼与安慰剂在代谢性酸中毒合并慢性肾脏病患者中的比较：一项多中心、随机、双盲、对照、3 期临床试验。
Lancet. 2019 Apr 6;393(10179):1417-1427. doi: 10.1016/S0140-6736(18)32562-5. Epub 2019 Mar 8.
9
Approach to the Treatment of Chronic Metabolic Acidosis in CKD.慢性肾脏病中慢性代谢性酸中毒的治疗方法。
Am J Kidney Dis. 2016 Apr;67(4):696-702. doi: 10.1053/j.ajkd.2015.12.016. Epub 2016 Jan 6.
引用本文的文献
1
Correlation and Diagnostic Value of Serum RBP4 and sRAGE and the Condition of Patients with Chronic Kidney Disease.血清视黄醇结合蛋白4（RBP4）和可溶性晚期糖基化终末产物受体（sRAGE）与慢性肾脏病患者病情的相关性及诊断价值
Evid Based Complement Alternat Med. 2021 Oct 27;2021:6166528. doi: 10.1155/2021/6166528. eCollection 2021.
Zotero 插件